These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
266 related articles for article (PubMed ID: 26921116)
1. Investigating the efficacy of an individualized metacognitive therapy program (MCT+) for psychosis: study protocol of a multi-center randomized controlled trial. Schneider BC; Brüne M; Bohn F; Veckenstedt R; Kolbeck K; Krieger E; Becker A; Drommelschmidt KA; Englisch S; Eisenacher S; Lee-Grimm SI; Nagel M; Zink M; Moritz S BMC Psychiatry; 2016 Feb; 16():51. PubMed ID: 26921116 [TBL] [Abstract][Full Text] [Related]
2. Moderators of treatment efficacy in individualized metacognitive training for psychosis (MCT+). Leanza L; Studerus E; Bozikas VP; Moritz S; Andreou C J Behav Ther Exp Psychiatry; 2020 Sep; 68():101547. PubMed ID: 31980132 [TBL] [Abstract][Full Text] [Related]
3. Individualized Metacognitive Training (MCT+) Reduces Delusional Symptoms in Psychosis: A Randomized Clinical Trial. Balzan RP; Mattiske JK; Delfabbro P; Liu D; Galletly C Schizophr Bull; 2019 Jan; 45(1):27-36. PubMed ID: 30376124 [TBL] [Abstract][Full Text] [Related]
5. Sustained antipsychotic effect of metacognitive training in psychosis: a randomized-controlled study. Favrod J; Rexhaj S; Bardy S; Ferrari P; Hayoz C; Moritz S; Conus P; Bonsack C Eur Psychiatry; 2014 Jun; 29(5):275-81. PubMed ID: 24176646 [TBL] [Abstract][Full Text] [Related]
6. Metacognitive group training for schizophrenia spectrum patients with delusions: a randomized controlled trial. van Oosterhout B; Krabbendam L; de Boer K; Ferwerda J; van der Helm M; Stant AD; van der Gaag M Psychol Med; 2014 Oct; 44(14):3025-35. PubMed ID: 25066223 [TBL] [Abstract][Full Text] [Related]
7. Sustained and "sleeper" effects of group metacognitive training for schizophrenia: a randomized clinical trial. Moritz S; Veckenstedt R; Andreou C; Bohn F; Hottenrott B; Leighton L; Köther U; Woodward TS; Treszl A; Menon M; Schneider BC; Pfueller U; Roesch-Ely D JAMA Psychiatry; 2014 Oct; 71(10):1103-11. PubMed ID: 25103718 [TBL] [Abstract][Full Text] [Related]
8. Complementary group Metacognitive Training (MCT) reduces delusional ideation in schizophrenia. Moritz S; Veckenstedt R; Bohn F; Hottenrott B; Scheu F; Randjbar S; Aghotor J; Köther U; Woodward TS; Treszl A; Andreou C; Pfueller U; Roesch-Ely D Schizophr Res; 2013 Dec; 151(1-3):61-9. PubMed ID: 24183707 [TBL] [Abstract][Full Text] [Related]
9. The Efficacy of Metacognitive Training for Delusions in Patients With Schizophrenia: A Meta-Analysis of Randomized Controlled Trials Informs Evidence-Based Practice. Liu YC; Tang CC; Hung TT; Tsai PC; Lin MF Worldviews Evid Based Nurs; 2018 Apr; 15(2):130-139. PubMed ID: 29489070 [TBL] [Abstract][Full Text] [Related]
10. Individualized metacognitive therapy for delusions: A randomized controlled rater-blind study. Andreou C; Wittekind CE; Fieker M; Heitz U; Veckenstedt R; Bohn F; Moritz S J Behav Ther Exp Psychiatry; 2017 Sep; 56():144-151. PubMed ID: 27919404 [TBL] [Abstract][Full Text] [Related]
11. Individualized metacognitive therapy program for patients with psychosis (MCT+): introduction of a novel approach for psychotic symptoms. Vitzthum FB; Veckenstedt R; Moritz S Behav Cogn Psychother; 2014 Jan; 42(1):105-10. PubMed ID: 23631928 [TBL] [Abstract][Full Text] [Related]
12. The efficacy of extended metacognitive training for psychosis: A randomized controlled trial. Ishikawa R; Ishigaki T; Shimada T; Tanoue H; Yoshinaga N; Oribe N; Morimoto T; Matsumoto T; Hosono M Schizophr Res; 2020 Jan; 215():399-407. PubMed ID: 31471248 [TBL] [Abstract][Full Text] [Related]
13. Randomized control trial to assess the efficacy of metacognitive training compared with a psycho-educational group in people with a recent-onset psychosis. Ochoa S; López-Carrilero R; Barrigón ML; Pousa E; Barajas A; Lorente-Rovira E; González-Higueras F; Grasa E; Ruiz-Delgado I; Cid J; Birulés I; Esteban-Pinos I; Casañas R; Luengo A; Torres-Hernández P; Corripio I; Montes-Gámez M; Beltran M; De Apraiz A; Domínguez-Sánchez L; Sánchez E; Llacer B; Pélaez T; Bogas JL; Moritz S; Psychol Med; 2017 Jul; 47(9):1573-1584. PubMed ID: 28166848 [TBL] [Abstract][Full Text] [Related]
14. Metacognitive training for schizophrenia: a multicentre randomised controlled trial. Briki M; Monnin J; Haffen E; Sechter D; Favrod J; Netillard C; Cheraitia E; Marin K; Govyadovskaya S; Tio G; Bonin B; Chauvet-Gelinier JC; Leclerc S; Hodé Y; Vidailhet P; Berna F; Bertschy AZ; Vandel P Schizophr Res; 2014 Aug; 157(1-3):99-106. PubMed ID: 24972754 [TBL] [Abstract][Full Text] [Related]
15. Long-term efficacy of Metacognitive Training for Depression (D-MCT): A randomized controlled trial. Jelinek L; Faissner M; Moritz S; Kriston L Br J Clin Psychol; 2019 Sep; 58(3):245-259. PubMed ID: 30556583 [TBL] [Abstract][Full Text] [Related]
16. Decreasing self-reported cognitive biases and increasing clinical insight through meta-cognitive training in patients with chronic schizophrenia. Gawęda Ł; Krężołek M; Olbryś J; Turska A; Kokoszka A J Behav Ther Exp Psychiatry; 2015 Sep; 48():98-104. PubMed ID: 25775947 [TBL] [Abstract][Full Text] [Related]
17. The influence of metacognitive training on delusion severity and metacognitive ability in schizophrenia. Erawati E; Keliat BA; Helena N; Hamid A J Psychiatr Ment Health Nurs; 2014; 21(9):841-7. PubMed ID: 24548341 [TBL] [Abstract][Full Text] [Related]
18. Metacognitive training for psychosis (MCT): past, present, and future. Moritz S; Menon M; Balzan R; Woodward TS Eur Arch Psychiatry Clin Neurosci; 2023 Jun; 273(4):811-817. PubMed ID: 35338378 [TBL] [Abstract][Full Text] [Related]
19. Sowing the seeds of doubt: a narrative review on metacognitive training in schizophrenia. Moritz S; Andreou C; Schneider BC; Wittekind CE; Menon M; Balzan RP; Woodward TS Clin Psychol Rev; 2014 Jun; 34(4):358-66. PubMed ID: 24866025 [TBL] [Abstract][Full Text] [Related]
20. Assessing the efficacy and feasibility of providing metacognitive training for patients with schizophrenia by mental health nurses: A randomized controlled trial. de Pinho LMG; Sequeira CADC; Sampaio FMC; Rocha NB; Ozaslan Z; Ferre-Grau C J Adv Nurs; 2021 Feb; 77(2):999-1012. PubMed ID: 33222210 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]